Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results

DUBLIN, Calif., Oct. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), today reported financial results for the third quarter ended September 30, 2012. The Company reported a net loss for the 2012 third quarter of $1.8 million, or $0.02 per basic and diluted share, compared with a net loss of $1.1 million, or $0.01 per basic and diluted share, for the same prior year period. The Company reported net income for the nine months ended September 30, 2012 of $3.7 million, or $0.04 per basic and diluted share, compared with a net income of $5.3 million, or $0.08 per basic and diluted share, for the same prior year period.